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CHAPTER ONE:  INTRODUCTION 
1.1 BACKGROUND 
The Government of the Republic of the Union of Myanmar has been 
implementing reforms on economics, social, health, education as well as policies to 
promote country’s economic development. The government has embraced wide-ranging 
reforms under the framework of economics and social reform. Fiscal reform is one kind 
of the framework of economic and social reform. Providing goods and services is to 
achieve various economic and social objectives of the government for their citizens. The 
effectiveness of supporting these goods and services is important, not only in the size of 
the contribution of the government and the private sector but also in the macroeconomic 
stabilization and economic development. 
Investing in health is a kind of investment which has many positive spillover 
effects on economic prosperity through various ways such as education, productivity, 
investment, and demographics. If the children are more healthy and well-nourished, they 
have more chance to go to school and live more longer. This can be directly affected to 
improve human development. In the production sector, more healthy people can more 
work hard and less have to take days off. Besides, these people can save more money 
and increase living standard. As the nation, when their citizens are healthier, the capacity 
of the country’s productivity will be higher. In demographics, when mortality rates 
decrease, the proportion of working people to their dependents will be increased. From 
this, a lot of effects, boosting in health sector can improve not only individually income 
but also national income. At the national level, the economic result is increasing the gross 
domestic product. 
 
1.2 PROBLEM STATEMENT 
According to UN Children's Fund (UNICEF) in 2013, malnutrition, malaria, 
anaemia, and premature birth rate are the main health problems plaguing Myanmar.  
Nearly 10 percent of newborns babies had low birth weight. Every year, around 56,000 
children in Myanmar die before they are five years old. Between 2001 and 2011, total 
health expenditure of Myanmar, which is the lowest country among the South-East Asia 
and Western Pacific Regions of the WHO, was about 2.0 percentage of Gross Domestic 
Product (GDP) (Fig. 3.1).  
 
Household’s out-of-pocket (OOP) payments which are the 79.3% of the total 
health expenditure is the major source for health sector because of low government 
spending which is just 13.6% of total health expenditure in 2011. Donation payments 
which are 7.1% of total health expenditure, half of that government spending are 
significant. The Ministry of Health (MOH) used 3–5% of the budget for medical goods 
so that expenditure is not adequate to meet demand. A larger portion of the budget is 
used for health-related functions which are food and drug control, research and 
development, capital formation, nutrition promotion and education, environmental health 
and 18 education and training of health personnel. 
 
1.3 STUDY OBJECTIVES 
The objective of this paper is to analyze the effectiveness of Myanmar’s 
government health expenditure on health outcomes, especially in the infant mortality rate 
by comparing with other’s ASEAN countries over the period 1995 and 2014. By 
analyzing the data of six ASEAN countries, we can see the results and determine how to 
change the policy to improve the health outcomes of Myanmar. 
 
1.4 STUDY SIGNIFICANCE 
The study analyzes not only the effectiveness of public health expenditures but 
also other socio-economic factors such as life expectancy, improved sanitation facilities, 
improved water source, urban population, food production index, GDP per capita, 
maternal mortality ratio and prevalence of HIV on the infant mortality rate in the ASEAN 
community with high statistical significance. From this analysis, reasonable high policy 
recommendation can be implemented for Myanmar. This research would prove to be 
useful to improve health outcomes, economic development, and budget allocation for the 
health sector. 
 
1.5 STUDY MOTIVATION 
Analyzing the effect of government health expenditure and other’s health 
outcomes are the motivation of this paper. Examining data in advance on Myanmar show 
that the trend of public health expenditure is increasing, while health indicators such as 
life expectancy rate was increasing and infant mortality rates are decreasing dramatically 
from 1995 to 2014. The effect of others’ indicators by comparing among ASEAN 
Community will also be conducted to arrive at an overall picture. 
 
1.6 RESEARCH QUESTIONS AND HYPOTHESES 
The important questions that would be attempted to be answered by this paper, is 
whether public health expenditure in the ASEAN Community has an impact on the health 
outcomes. 
1. Does reduction in infant mortality rate improves as public health expenditure 
increases? 
2. How does infant mortality rate relate to Socio-Economic factors? 
 
1.7 THE STRUCTURE OF THE PAPER 
Five chapters are included in this paper. Chapter One is Introduction which 
briefly explains about my research thesis. After the introduction, the existing literature is 
reviewed in Chapter Two. Following which, the analytical methodology and data are 
presented in Chapter Three, the related results are discussed in Chapter Four and policy 
implications and conclusions are shown in Chapter Five.  
 
 
 
 
 
CHAPTER TWO:  LITERATURE REVIEW 
 
Andrew, Finn and Phyllida (2013) reported that although the health sector in 
Myanmar faces a lot of challenges, there is a reduction in the under-five and maternal 
mortality rate between 1998 and 2010. Moreover, health’s expenditure portion of the 
GDP has been increasing by 1% a year, from the previous 0.9% in 2010, and has a target 
of 5 % by 2015. Out of pocket total health spending is about 80 - 90%. They also 
mentioned that there have 3 donors for the external health funding: the 3MDGs 
(Millennium Development Goals) Fund; the Global Fund and GAVI (The Global 
Alliance for Vaccines and Immunizations). Currently, UNOPS (United Nations Office 
for Project Services) arranges Global Fund and 3DMG resources, while GAVI funds are 
controlled by UNICEF and WHO.(Andrew, Finn, & Phyllida, 2015) 
In neonatal and child health country profile of Myanmar, the major indicators of 
human and other resources of health sectors are nurses & midwives per 10,000 
population, community health workers per 10,000 population, physicians per 10,000 
population and hospital beds per 10,000 population. In 2013, infant mortality rate per 
1,000 live births is 39.8 and under-five mortality rate is 50.5 respectively. This report 
showed that there are inequalities in under-five mortality depending on the place of 
residence (urban and rural), position of wealth (highest and lowest) and mother’s 
education (highest and lowest). (Profile & C. H, 2014) 
Maternal and Newborn Health Country Profiles of Myanmar mentioned that 
pneumonia, diarrhoea, and other complications are the major causes of child mortality. 
Urban children and the richest children are more likely to survive than children in rural 
areas or those who belong to a poorer socio-economic status. (Health & Profiles, 2015) 
Among the main health problems in Myanmar, the rate of innutritious children 
who are under five years old has obviously improved in 1997, 2000. 2003 and 2010. 
According to prevalence of worm infestation, Anemia in pregnant women and children 
under-five is also raise. Malaria, Tuberculosis, and HIV/AIDS are the most three 
important diseases of public health in Myanmar. (Pyi, Council, & Index, 2012) 
During 1990 and 2010, the mortality rate of children who are under five has fallen 
from 130 per 1000 live births to 46 per 1000 live births. If this rate continues, Myanmar 
is likely to achieve the target of 43 in MDG 4 (two-thirds reduction in U5MR). Although 
the maternal mortality rate has been decreasing regularly, it remains high and cannot be 
able to achieve the MDG 5 target of three-quarters reduction with comparison its baseline 
year 1990. In the 1990s, the decreasing of mortality in children has slowed down lately. 
In analyzing the gap narrowed between under-five mortality rate and infant mortality 
rate, most of the under-five mortality rate happens in the first-year old. Life expectancy 
at birth is higher in urban area than it is in rural. (Pyi et al., 2012)  
Department of Health manages primary health care, environmental sanitation, 
nutrition promotion and research, maternal and child health services, and school health 
services. The support of primary and secondary healthcare is the Township Health 
Department which is working for 100,000 to 200,000 people. 
 The Rwandan Government’s measures may be useful to look at. Rwanda 
took several steps to improve access to medical facilities and related infrastructure, 
proxied by urbanization, consumption of nutritious food, and reduction of HIV/AIDS 
prevalence rates, improving per capita income and broadening access to water and 
sanitation to reduce the infant mortality rate. Increasing access to pipe water may 
significantly reduce the number of hours and kilometres girls must travel to get and carry 
water, thereby providing them more time to focus on their education, by including 
increased time for their after-school assignments. This, in turn, has the potential to reduce 
the infant mortality rate. Moreover, government expenditures should place more 
emphasis on the expansion of water and sanitation expenditures since they are more 
effective in achieving the objective of health sector public expenditures (Abel, 2014). 
Chunling, Matthe, Paul, Katherine, Dean, and Christopher (2001) showed that 
“public health financing from domestic sources in developing countries improved by 
nearly 100% from 1995 to 2006. At the country level, while many regions increased their 
government health expenditures, many sub-Saharan African countries decreased 
expenditures.” The statistical analysis presented that domestic government health 
expenditures was reduced by $0.43 to $1.14 and Development Assistance for Health 
(DAH) to government had a negative effect on domestic government health spending. 
However, DAH to the non-governmental sector had a good effect on domestic 
government health spending. Both results were solid to multiple conditions and analyses. 
Another factor which is debt relief had no measurable effect on domestic government 
health spending.(Lu et al., 2001) 
 Anil Shetty and Shraddha Shetty mentioned that “Asian countries had a 
decrease in IMR by increasing health expenditure and mostly had a large portion of their 
GDP in health spending. Singapore, South Korea, Qatar and the UAE had a higher per 
capita income. Therefore, they could spend more on health and achieved better results 
than their peers. In Middle Eastern countries, they had higher state subsidizing for health. 
Thus, private health expenditure is very low. There is a larger share of private health 
expenditure in poorer countries because of lower quality of accessing in public health 
care. In determining mortality, public health spending, gross national income/capita, 
poverty, inequality, and female illiteracy were the important socioeconomic predictors. 
In that study, private health spending did not have a positive significant effect on infant 
mortality rate due to affordability and impacting private health care. On the other hand, 
the effectiveness of public health expenditure is weak in society.” (Shetty & Shetty, 
2014) 
 Sonia Bhalotra identified that “public health expenditure seems to have 
no effect on society.” They have argued that this may be a sign of balancing between 
public and private inputs. It may also be associated with the public health expenditure in 
India is non-progressive. It can be more progressive by making allocations in favour of 
public health, water and family welfare programmed in rural areas and, within rural areas 
and by rising information and access for politically and socially deprived groups. The 
impact of health expenditure is not the same between the states, that have no obvious 
correlation to primary levels of mortality rate and their income.(Bhalotra, 2007) 
 From 1960s to 1980s, Infant Mortality Rate in China decreased 
dramatically and then stabilized. They found that the infant mortality risks of girls at the 
national level expanded from 1990 to 2000. IMR in urban areas was significantly lower 
than in rural areas and the gap of IMR extended from 1.5 to 2.1 during 1981 and 2000. 
At the same time, the ratio of female to male IMR rose from 0.9 to 1.3. During 1990-
2000, female IMR in rural areas increased from 34.9 to 36.7. Rural residents, in general, 
prefer having boys, and due to the family planning policy, there are more boys are born 
than girls in China. They examine the regional distribution of IMR and overall regional 
inequality was high within-rural, within-urban, and between rural-urban inequalities 
from 1981 to 2000. It seems that in both rural and urban areas, the regional variation in 
health outcomes has widened over the reform period.(Zhang & Kanbur, 2005) 
CHAPTER THREE:  MODEL SPECIFICATION AND METHODOLOGY 
 
3.1 MODEL SPECIFICATION 
 In this research, it uses a panel data fixed effects regression by using the STATA 
econometric software, for the period between 1995 and 2014, to demonstrate the 
effectiveness of public health expenditures on health outcomes that is infant mortality 
rate. It includes the currently six ASEAN Community Countries (i.e. Myanmar, 
Indonesia, Malaysia, Thailand, Cambodia, and Singapore). The data in this study came 
from the “World Bank’s World Development Indicators database”. The standard static 
model enables the predicator intercepts to represent country effects, it takes the structure, 
with “i” defining each county, whereas “t” defines a period as follows: 
LIMRit = β0 + β1LPHEit + β2LISFit + β3LIWSit + β4LUPit + β5LFPIit + β6LGDPit + 
β7MMRit + β8LPofHIVit + µit …………………………………………………………. (1) 
LLEit = β0 + β1LPHEit + β2LISFit + β3LIWSit + β4LUPit + β5LFPIit + β6LGDPit + 
β7LPofHIVit + µit ……………………………………………………………………... (2) 
Where: 
LIMR = logarithmic transformation of Infant Mortality Rate. 
LLE = logarithmic transformation of Life Expectancy at birth. 
LPHE = logarithmic transformation of Public Health Expenditures as a % of government 
expenditures (“- sign in Model 1 and + sign in Model 2”). LPHE is the main indicator 
of this study. 
LISF = logarithmic transformation of Improved Sanitation Facilities (“- sign in Model 
1 and + sign in Model 2”).  
LIWS = logarithmic transformation of Improved Water Source (“- sign in Model 1 and 
+ sign in Model 2”).  
LUP = logarithmic transformation of Urban Population (“- sign in Model 1 and + sign 
in Model 2”).  
LFPI = logarithmic transformation of Food Production Index (“- sign in Model 1 and 
+ sign in Model 2”).  
LGDP = logarithmic transformation of Gross Domestic Product per capita (“- sign in 
Model 1 and + sign in Model 2”).  
LMMR = logarithmic transformation of Maternal Mortality Ratio (“+ sign in Model 1 
and - sign in Model 2”).  
LPofHIV= logarithmic transformation of Prevalence of HIV (“= sign in Model 1 and -
sign in Model 2”).  
µit = Error Term 
 Model 1 measures the effectiveness of Public Health Expenditures (PHE) on 
reducing the Infant Mortality Rate (IMR), while Model 2 measures Public Health 
Expenditures (PHE) effectiveness on increasing Life Expectancy at birth (LE). The 
expected sign of the controlled variables is shown in above variables’ explanation. 
 In this research, while analyzing the effectiveness of Public Health Expenditures 
on health outcomes such as Infant Mortality Rate and Life Expectancy, GDP per capita, 
Urban Population, Food Production Index, Improved Sanitation Facilities, Improved 
Water Source, Maternal Mortality Ratio, and Prevalence of HIV are controlled for these 
two models.  
 
 
3.2 VARIABLES AND DATA DESCRIPTION 1 
1. Mortality rate, infant (per 1,000 live births) 
The World Bank defines “the Infant mortality rate is the number of infants dying 
before reaching one year of age, per 1,000 live births in a given year”. This is one of the 
health outcomes and is used as the dependent variable. 
2. Life expectancy at birth, total (years) 
In the World Bank’s definition, “Life expectancy at birth indicates the number of 
years a newborn infant would live if prevailing patterns of mortality at the time of its 
birth were to stay the same throughout its life”. This is also one kind of health outcomes 
and being tested as a dependent variable in this study. 
3. Health expenditure, public (% of government expenditure) 
According to World Bank, “Public health expenditure consists of recurrent and 
capital spending from government (central and local) budgets, external borrowings, and 
grants (including donations from international agencies and nongovernmental 
organizations), and social (or compulsory) health insurance funds.”  These expenditures 
can directly affect the good health outcomes and so we used this variable to know how 
may effective on infant mortality rate and life expectancy. 
4. Improved sanitation facilities (% of population with access) 
As shown in World Bank, this means that “access to improved sanitation facilities 
refers to the percentage of the population using improved sanitation facilities. Improved 
sanitation facilities are likely to ensure hygienic separation of human excreta from human 
contact. They include flush/pour flush (to piped sewer system, septic tank,  pit latrine),  
1 As indicated in this chapter, the data is used from “World Bank’s World Development 
Indicators database”. Therefore, the definitions of all variables are also used from the 
World Bank’s definitions to keep the meanings as defined by the World Bank.  
ventilated improved pit (VIP) latrine, pit latrine with slab, and composting toilet.” This 
variable is also important to reduce the infant mortality rate and increase life expectancy. 
5. Improved water source (% of population with access) 
The World Bank also explain that “access to an improved water source refers to 
the percentage of the population using an improved drinking water source. The improved 
drinking water source includes piped water on premises (piped household water 
connection located inside the user’s dwelling, plot, or yard), and other improved drinking 
water sources (public taps or standpipes, tube wells or boreholes, protected dug wells, 
protected springs, and rainwater collection).” Cleaning water is needed for good health 
result. Most of the diseases are occurred by falling water access system. 
6. Urban population (% of total) 
As per the World Bank, “Urban population refers to people living in urban areas 
as defined by national statistical offices. The data are collected and smoothed by United 
Nations Population Division.” Health outcomes can be different between rural and urban 
area. Thus, I used this variable as one kind of independent variable which is affected the 
infant mortality rate and life expectancy. 
7. Food production index (2004-2006=100) 
The World Bank defines “Food production index covers food crops that are 
considered edible and that contain nutrients. Coffee and tea are excluded because, 
although edible, they have no nutritive value.” Food is also important for human being 
because we cannot live without food. Thus, food production index is used to analyze the 
reduction infant mortality rate and increasing life expectancy. 
 
8. GDP per capita (constant 2010 US$) 
According to World Bank, “GDP per capita is gross domestic product divided by 
midyear population. GDP is the sum of gross value added by all resident producers in the 
economy plus any product taxes and minus any subsidies not included in the value of the 
products. It is calculated without making deductions for depreciation of fabricated assets 
or for depletion and degradation of natural resources. Data are in constant 2010 U.S. 
dollars.” It can demonstrate the image of people’s wealth and health to analyze the health 
outcomes in this study. 
9. Maternal mortality ratio (modeled estimate, per 100,000 live births) 
In the World Bank’s definition, “Maternal mortality ratio is the number of women 
who die from pregnancy-related causes while pregnant or within 42 days of pregnancy 
termination per 100,000 live births. The data are estimated with a regression model using 
information on the proportion of maternal deaths among non-AIDS deaths in women 
ages 15-49, fertility, birth attendants, and GDP.” This is also concerned with studying to 
reduce infant mortality rate and increase life expectancy. 
10. Prevalence of HIV, total (% of population ages 14-49) 
The World Bank defines “Prevalence of HIV refers to the percentage of people 
ages 15-49 who are infected with HIV.” HIV prevalence rates can reflect the infant 
mortality rate and life expectancy in each country's population. In many developing 
countries, most new infections occur in young children through their parents. 
To be clear and easy, a tabular draw in Table 1 shows the acronym and description of the 
data used in this study and their related sources that is used from that website are shown 
below: 
 
Table 1: Data and their related sources 
 
   
VARIABLE ACRONYM DESCRIPTION SOURCE 
“Mortality rate, infant (per 1,000 
live births)” 
IMR Dependent Variable WDI 
“Life expectancy at birth, total 
(years)” 
LE Dependent Variable WDI 
“Health expenditure, public (% of 
government expenditure)” 
PHE Independent Variable WDI 
“Improved sanitation facilities (% of 
population with access)” 
ISF Independent Variable WDI 
“Improved water source (% of 
population with access” 
IWS Independent Variable WDI 
“Urban population (% of total)” UP Independent Variable WDI 
“Food production index (2004-
2006=100)” 
FPI Independent Variable WDI 
“GDP per capita (constant 2010 
US$)” 
GDP Independent Variable WDI 
“Maternal mortality ratio (modeled 
estimate, per 100,000 live births)” 
MMR Independent Variable WDI 
“Prevalence of HIV, total (% of 
population ages 14-49)” 
PofHIV Independent Variable WDI 
    
 
3.3 HAUSMAN TEST 
 In panel data analysis, we need to use the Hausman test to choose between fixed 
effects model and random effects model.  According to Statistical Theory, if the p-value 
is small (p-value < 0.05), it can reject the null hypothesis and the preferred model is fixed 
effects. If the p-value is not small (p-value >0.05), it can accept the null hypothesis and 
the random effects model is preferred. As shown in below two results, fixed effects model 
is more preferred for this study.  
 
Hausman Test for Infant Mortality Rate  
 
 
Hausman Test for Life Expectancy 
 
 
 
                (V_b-V_B is not positive definite)
                Prob>chi2 =      0.0002
                          =       30.09
                  chi2(8) = (b-B)'[(V_b-V_B)^(-1)](b-B)
    Test:  Ho:  difference in coefficients not systematic
            B = inconsistent under Ha, efficient under Ho; obtained from xtreg
                           b = consistent under Ho and Ha; obtained from xtreg
                                                                              
     LPofHIV     -.0391686    -.0214069       -.0177617        .0895455
        LMMR      .4660973     .2601157        .2059817        .1113769
        LGDP      -.366942     .5365565       -.9034986        .1392414
        LFPI     -.4469161    -.4483049        .0013889        .1180772
         LUP      -.849854    -1.082012        .2321578        .2434259
        LIWS      1.864231    -3.703347        5.567578        .9823218
        LISF     -.1436269     1.527165       -1.670792         .381855
        LPHE      .1741363    -.0545521        .2286883         .077297
                                                                              
                     re           fe         Difference          S.E.
                    (b)          (B)            (b-B)     sqrt(diag(V_b-V_B))
                      Coefficients     
. hausman re fe
                (V_b-V_B is not positive definite)
                Prob>chi2 =      0.0000
                          =     3830.31
                  chi2(7) = (b-B)'[(V_b-V_B)^(-1)](b-B)
    Test:  Ho:  difference in coefficients not systematic
            B = inconsistent under Ha, efficient under Ho; obtained from xtreg
                           b = consistent under Ho and Ha; obtained from xtreg
                                                                              
     LPofHIV        .00838    -.0011084        .0094884        .0052618
        LGDP      .0334045     -.013714        .0471185        .0074167
        LFPI      .0213905      .003993        .0173975        .0070399
         LUP     -.0070808     .0685089       -.0755897        .0135982
        LIWS      .1501362     .4308221       -.2806858         .059737
        LISF      .0018639     -.090358        .0922219        .0203968
        LPHE      .0055614     .0011892        .0043722        .0038892
                                                                              
                     re           fe         Difference          S.E.
                    (b)          (B)            (b-B)     sqrt(diag(V_b-V_B))
                      Coefficients     
. hausman re fe
. 
CHAPTER FOUR:  RESULTS OF EMPIRICAL ANALYSIS AND RELATED 
DISCUSSION 
 
4.1 DESCRIPTIVE ANALYSIS 
 In analyzing my research study, firstly I would like to present the descriptive 
statistics such as Summary statistics and Correlation Matrix with Logarithmic Variables 
as shown in Table 2 below. 
Table 2: Descriptive Statistics 
Panel A: Summary Statistics 
 
 In this summary statistics, we can easily see the total observation, Mean, Standard 
Deviation, Minimum and Maximum for each variable. Although some variables have 
120 observations, some are not because of the data unavailable.  
Panel B: Correlation Matrix with Logarithmic Variables 
 
       Year1          120        10.5    5.790459          1         20
    Country1          120         3.5    1.714986          1          6
      PofHIV          100        .871    .5207405         .1          2
         MMR          120    157.7917    157.9822         10        730
                                                                       
         GDP          120    9198.027    13960.81   237.9569   51440.82
         FPI          114    101.5625    28.16478      57.32     181.39
          UP          120    49.48316    27.23802     17.311        100
         IWS          120       82.25    17.89935       30.3        100
         ISF          120    71.46167    27.68097        7.7        100
                                                                       
         PHE          120    8.000927    5.438058    .765524   23.24722
         IMR          120    29.16583    24.19737        2.2       88.2
          LE          120    69.58285    6.507457   55.12166   82.64634
        Year            0
     Country            0
                                                                       
    Variable          Obs        Mean    Std. Dev.       Min        Max
. su
     LPofHIV    -0.0543  -0.0376   0.3793  -0.0487  -0.2052  -0.3974   0.0449  -0.1539  -0.3116   1.0000
        LMMR    -0.8891   0.8441  -0.4988  -0.7701  -0.7951  -0.5763  -0.2750  -0.8089   1.0000
        LGDP     0.9329  -0.9264   0.4140   0.6808   0.8287   0.8749   0.2809   1.0000
        LFPI     0.4204  -0.2952   0.1825   0.2683   0.3741   0.1553   1.0000
         LUP     0.8066  -0.8307   0.0061   0.7279   0.8171   1.0000
        LIWS     0.9267  -0.7993   0.0509   0.9493   1.0000
        LISF     0.8287  -0.7233  -0.1078   1.0000
        LPHE     0.3334  -0.3469   1.0000
        LIMR    -0.9420   1.0000
         LLE     1.0000
                                                                                                        
                    LLE     LIMR     LPHE     LISF     LIWS      LUP     LFPI     LGDP     LMMR  LPofHIV
(obs=95)
. correlate LLE LIMR LPHE LISF LIWS LUP LFPI LGDP LMMR LPofHIV
 In above Table 2 - Panel B, it is shown that LPHE is negatively related to LIMR, 
LMMR and LISF. And then, LPHE is also positively related to LLE, LIWS, LUP, LFPI, 
LGDP and LPofHIV. LIMR is positively related to only LMMR and negative 
relationship with other variables. Although LLE is negatively related with LLIMR, 
LMMR and LPofHIV, it is positively related with other variables. 
 Secondly, as shown in Table 3, this is the tabular illustrations of Six ASEAN 
Countries and their Mean Variables between 1995 and 2014. 
Table 3: Six ASEAN Countries and their Mean Variables (1995-2014) 
 
 From the above data, Myanmar has the lowest mean of public health expenditure 
(PHE) (1.749923955) among the Six ASEAN Countries which has average of 
(8.000926687). Thailand is the highest public health expenditures mean (16.71713691) 
among Six ASEAN Countries. In the infant mortality rate, Cambodia is the highest mean 
(58.36) above the Six Countries’ mean (29.166) although his average public health 
expenditure (9.897081207) is above the average Six Countries. Myanmar has the second 
largest mean of infant mortality rate. Among these ASEAN Countries, Singapore has the 
highest life expectancy average (79.535) and Myanmar has the second lowest mean of 
life expectancy (63.319635) which are below the Six Countries’ average (69.582847). 
Visibly from the above data, Singapore has the fully improved water access and urban 
population. Otherwise, it does not have any data of HIV Prevalence Rate. 
COUNTRY LE IMF PHE ISF IWS UP FPI GDP MMR PofHIV 
MYANMAR 63.319635 54.425 1.749923955 68.3 71.59 29.0326 95.573684 623.957 264 0.77 
THAILAND 72.095302 16.24 16.71713691 92.175 93.915 37.79895 101.91842 4320.124 23.8 1.515 
MALASIA 73.428482 7.945 5.602025498 92.955 95.48 65.72825 95.645263 7995.064 53.3 0.605 
INDONESIA 67.061905 35.3 5.000707393 51.38 80.725 45.24885 99.346842 2670.013 220.45 0.225 
CAMBODIA 62.056756 58.36 9.897081207 24.125 51.79 19.0903 104.71105 605.249 370.6 1.24 
SINGAPORE 79.535 2.725 9.038685162 99.835 100 100 112.17947 38973.75 14.6  
 6 ASEAN 69.582847 29.166 8.000926687 71.462 82.25 49.48316 101.56246 9198.027 157.79 0.871 
Figure 1: Infant Mortality Rate’s trend in the Six ASEAN Countries 
 
 Figure 1 shows the movement of the infant mortality rate in the Six ASEAN 
Countries from 1995 to 2014. It can see visibly the trend of infant mortality rate. Before 
2005, Cambodia has the highest infant mortality rate and then it is rapidly declined. After 
2005, Myanmar has the highest infant mortality rate even it is decreasing dramatically. 
From 1994 to 2015, Singapore has the lowest infant mortality rate below the value of 10 
per 1000 live births.  
Figure 2: Life Expectancy’s trend in the Six ASEAN Countries 
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Figure 2 demonstrates the trend of the life expectancy from 1995 to 2014 in the 
Six ASEAN Countries. The idea to illustrate the figure is to see clearly the process of life 
expectancy. Life expectancies of these Six ASEAN Countries are between 50 years and 
85 years. These are not too difference among these Six Countries and they are increasing 
slowly. 
 
Figure 3: Public Health Expenditure’s trend in the Six ASEAN Countries 
 
 
Figure 3 displays the movement of the public health expenditures in the Six 
ASEAN Countries between 1995 and 2014. Thailand is obviously increased the public 
health expenditures after 2014. Myanmar is the lowest public health expenditures among 
these Six ASEAN Countries. Thus, the Myanmar Government is trying to increase health 
expenditures after 2011 in which is changed to New Democracy Government System. 
The fluctuation of Cambodia is so high and it is intensely declined under the average 
level. 
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Figure 4: Improved Sanitation Facilities’ trend in the Six ASEAN Countries 
 
 
Figure 4 illustrates the trend of the improved sanitation facilities in the Six 
ASEAN Countries from 1995 to 2014. In this figure, although Cambodia has the lowest 
sanitation system among these 6 countries, we can see that it has been increasing year by 
year. The sanitation facility of the Singapore is the best which is almost the 100 percent. 
The results of the sanitation facilities of Thailand and Malaysia are not too different.  
 
Figure 5: Improved Water Source’s trend in the Six ASEAN Countries 
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Figure 5 presents the movement of the improved water source of the Myanmar, 
Thailand, Malaysia, Indonesia, Cambodia, and Singapore for these 20 years. Cambodia 
has the lowest water source among these six countries. Then, we can see it has been 
significantly increasing. Indonesia has the medium situation of water source among these 
countries. Malaysia and Thailand have similar result and Singapore has the highest water 
source. Water sources is essential to live healthy and for improving health outcomes. 
 
Figure 6: Urban Population’s trend in the Six ASEAN Countries 
 
 
Figure 6 shows the situation of the urban population in the Six ASEAN Countries 
between 1995 and 2014. Singapore has the highest urban population, which has the full 
value of 100. Therefore, Singapore has no rural area. On the other side, Cambodia has 
the lowest urban population. In this figure, we can see that the situation of urban 
population is not noticeably changed for all Six ASEAN Countries. Thus, we can 
conclude that the living standard of the people from these countries has slowly changed. 
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Figure 7: Food Production Index’s trend in the Six ASEAN Countries 
 
Figure 7 illustrates the movements of Food Production Index for the Six ASEAN 
Countries from 1995 to 2014. Before 2000, food production of index of Singapore is 
extremely higher than other five countries. Between 1999 and 2000, it has sharply 
declined and a little fluctuated until 2014. Other Five Countries has been increasing 
slightly. After 2008, Cambodia has the highest food production index among these Six 
ASEAN Countries. After 2005, Singapore has the lowest food production index among 
these countries. 
Figure 8: GDP per capita variable’s trend in the Six ASEAN Countries 
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Figure 8 demonstrates the trends of the GDP per capita from 1995 to 2014 in the 
Six ASEAN Countries. In this figure, GDP per capita of Singapore is extremely large 
among Six ASEAN Countries. Moreover, it has been increasing strongly comparing with 
other countries. Myanmar and Cambodia have the lowest GDP per capita and their values 
are quite similar. The GDP per capita of the other five countries which are excluding 
Singapore are not too different and under the value of 10000. 
 
Figure 9: Maternal Mortality Rate’s trend in the Six ASEAN Countries 
 
 
Figure 9 presents the movement of maternal mortality rate of the Myanmar, 
Thailand, Malaysia, Indonesia, Cambodia, and Singapore for 20 years. From 1995 to 
2007, the maternal mortality rate of Cambodia is declined steeply. Moreover, Myanmar 
and Indonesia have been decreasing gradually. Maternal mortality rates of Malaysia, 
Thailand and Singapore are under the value of 100 per 100,000 live births and then their 
rates are quite similar. 
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Figure 10: Prevalence of HIV’s trend in the Six ASEAN Countries 
 
 
Figure 10 shows the situation of the prevalence of HIV in the Six ASEAN 
Countries between 1995 and 2014. In this figure, we can see that no HIV prevalence rate 
in Singapore because it cannot be found the data about prevalence of HIV for Singapore. 
Cambodia had increased between 1995 and 1998 and then it declines dramatically. 
Before 2003, the prevalence of HIV in Indonesia is stable and later it is increasing slowly. 
We can obviously see the falling of HIV prevalence rate in Thailand. In Myanmar, it is 
a little increased before 2002 and then it is stable up to 2014. 
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4.2 REGRESSION RESULTS ON EFFECTIVENESS OF PUBLIC HEALTH 
EXPENDITURE IN REDUCING INFANT MORTALITY RATE AND 
INCREASING LIFE EXPECTANCY 
 
 As mentioned above Chapter-3, the collected data is analyzed with Panel data – 
Fixed effects regression model by using in STATA econometric software. Table 4 and 5 
presents the regression models 1 and 2 mentioned in Chapter 3. Initially, Table (4) 
illustrates the variation in infant mortality rate in Six ASEAN Countries between the 
period 1995 and 2014. 
 
Table 4: Public Health Expenditures and Infant Mortality Rate 
Infant Mortality Rate Fixed Effects Fixed Effects Fixed Effects 
“Variables” Model (1) Model (2) Model (3) 
    
LPHE -0.055** -0.026 0.051 
 (0.022) (0.026) (0.031) 
LISF 1.527***   
 (0.234)   
LIWS -3.703*** -0.565*** -0.312 
 (0.496) (0.153) (0.189) 
LUP -1.082*** -1.065*** -1.198*** 
 (0.079) (0.096) (0.120) 
LFPI -0.448*** -0.562*** -0.146* 
 (0.070) (0.083) (0.077) 
LGDP 0.537*** 0.350***  
 (0.048) (0.048)  
LMMR 0.260*** 0.169* 0.296*** 
 (0.071) (0.086) (0.107) 
LPofHIV -0.021 0.061*** 0.090*** 
 (0.021) (0.021) (0.026) 
Constant 13.840*** 8.720*** 8.111*** 
 (1.206) (1.125) (1.429) 
    
Observations 95 95 95 
R-squared 0.978 0.966 0.945 
Standard errors in parentheses 
*** p<0.01, ** p<0.05, * p<0.1 
 
Anil Shetty and Shraddha Shetty (2014) found that Asian countries had a decrease 
in IMR by increasing health expenditure. In this study, Table (4) Model (1), LPHE is a 
negative relationship with LIMR as expected and statistically significant at 5 % level. 
LIWS, LUP and LFPI are also negatively related with LIMR with a statistical 
significance of 1% level. LMMR has a positive relationship with LIMR and as a 
statistical significance of 1% level. LISF and LGDP are positively related to LIMR, 
which is contrary to theory, and statistically significant. Moreover, LPofHIV is a negative 
relationship with LIMR that is opposing with the theory.  
In the same Table (4), LISF is excluded in Model (2) because the sign of LISF in 
model (1) was different from the theory and as statistically significant. Subsequently, 
although LPHE is negatively related with LIMR, it is statistically insignificant. LIWS, 
LUP and LFPI are negative relationship with LIMR along with a statistical significance 
of 1% level. Although LISF is excluded in model (2), LGDP is still opposing the theory 
and positive relationship with LIMR as a statistically significant. LMMR and LPofHIV 
are positively related with LIMR and as a statistically significant of 0.1 % and 1 % 
respectively. In Model (2), LPofHIV is consistency with the theory after removing the 
LIWS. 
Finally, in Model (3), both LISF and LGDP are left out from the analysis and the 
results show that LPHE is changed to be positive relationship with LIMR, which is 
contrary to theory, and as statistically insignificant. LIWS is negatively related with 
LIMR but not statistically significant. LUP and LFPI have negative relationship with 
LIMR and as statistically significant 1% and 0.01% respectively. Moreover, LMMR and 
LPofHIV are positively correlated with LIMR along with a significant of 1 % level.  
Table (5) will present the correlation of the life expectancy in the Six ASEAN 
Countries for 20 years that is from 1995 to 2014. 
 
Table 5: Public Health Expenditures and Life Expectancy 
Life Expectancy Fixed Effects  Fixed Effects  Fixed Effects  
“Variables” Model (1) Model (2) Model (3) 
    
LPHE 0.002 0.001 0.010*** 
 (0.002) (0.002) (0.002) 
LISF -0.099*** -0.090*** -0.083*** 
 (0.017) (0.018) (0.028) 
LIWS 0.430*** 0.431*** 0.398*** 
 (0.037) (0.038) (0.060) 
LUP 0.068*** 0.069***  
 (0.006) (0.006)  
LFPI -0.003 0.004 0.036*** 
 (0.005) (0.005) (0.006) 
LGDP -0.013*** -0.014*** -0.019*** 
 (0.004) (0.004) (0.006) 
LMMR -0.014***   
 (0.005)   
LPofHIV -0.003* -0.001 -0.002 
 (0.002) (0.002) (0.002) 
Constant 2.685*** 2.547*** 2.785*** 
 (0.090) (0.076) (0.116) 
    
Observations 95 95 95 
R-squared 0.994 0.993 0.983 
Standard errors in parentheses 
*** p<0.01, ** p<0.05, * p<0.1 
 
 In this study, Table (5) Model (1), LPHE is a positively correlated with 
LLE but as a statistically insignificant. LIWS and LUP are also positive relationship with 
LLE in a statistical significance of 1% level. Moreover, LMMR and LPofHIV are 
negatively related with LLE, at 1 % and 0.01% level of significance respectively. LISF 
and LGDP have negative coefficient signs, which is contrary to theory, at a statistical 
significance level of 1 %. LFPI has negative correlated with LLE, which is also different 
from theory, but statistically insignificant.  
In the same Table (5), LMMR is excluded in Model (2) to explain more the 
effectiveness of public health expenditures in increasing life expectancy. But the results 
show that LPHE is positive relationship with LLE and still as insignificant. LIWS and 
LUP are positively correlated with LLE, along with a statistical significance of 1% level. 
LFPI is positive relationship with LLE and it has statistically insignificant. And then, 
LPofHIV is negatively related with LLE and it is also not significant. In this model, LISF 
and LGDP are controversial with the theory. Both of LISF and LGDP have negative 
relationship with LLE and along with statistically significant.  
Finally, in Model (3), both LMMR and LUP are removed from the analysis and 
the results show that LPHE has positive relationship with LLE and it changed statistically 
significant of 1 % level. LPofHIV are negatively correlated with LLE, but not statistically 
insignificant. Also in this model, LISF and LGDP are still controversial with the theory. 
Both of LISF and LGDP have negative relationship with LLE and along with statistically 
significant.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER FIVE:  SUMMARY CONCLUSION AND POLICY IMPLICATION 
 
5.1 CONCLUSION 
 This research paper employed a panel data fixed effects regression by using the 
STATA econometric software, between the period 1995 and 2014, to express the 
effectiveness of public health expenditures on health outcomes such as infant mortality 
rate and life expectancy. The data used in this research are from the Six ASEAN 
Countries, which are Myanmar, Thailand, Cambodia, Malaysia, Indonesia, and 
Singapore. It is emphasized to give policy recommendation, especially for Myanmar by 
comparing with other Five ASEAN Countries.  
 It is shown in the result that Myanmar had the second largest of average infant 
mortality rate and it is above the 6 ASEAN Countries’ average. And then, Myanmar had 
second lowest of average life expectancy among other countries. Nevertheless, the 
average of public health expenditures is the lowest in Myanmar within these Six 
Countries. Although Cambodia had the second highest of average public health 
expenditures, it had the highest average of infant mortality rate and the lowest average 
of life expectancy.  
5.2 POLICY IMPLICATIONS 
 In the correlation matrix in Panel B, public health expenditure is negatively 
correlated with the improved sanitation facilities. It means that the higher the public 
health expenditures, the lower the improved sanitation system. The policy 
recommendation drawn from that result is that we need to invest to improve sanitation 
and sewage system. Most of the children under five are died every year due to diarrheal 
diseases. The improvement of water and sanitation is important to save infants and 
children from the incident of diseases such as diarrhoea and malaria.  
 Moreover, in this correlation matrix shows the positive relationship between 
public health expenditures and HIV prevalence rate. This means that the increasing 
public health expenditure cannot be able to reduce incidence of HIV/AIDS. It is because 
of spending public health expenditures do not affect in preventing and curing on HIV/ 
AIDS. So, it should be more emphasized on spending on that project.  
 In regression result Table (4) Model (1), we can see the negative relationship 
between infant mortality rate and public health expenditures. An increase in public 
expenditure on health care will reduce the infant mortality rate by 5.5 deaths per 1000 
live births. An improving water source by 1 percent will also decrease the infant mortality 
rate by 370.3 percent. In this result, an increasing GDP per capita cannot affect in 
reducing infant mortality rate. So, we are not able to decide reducing death of infant by 
viewing the GDP progress.   
 Increasing public health expenditures and medical facilities, improving water 
source, more providing food and nutritious, reduction of HIV/ AIDS prevalence rate are 
key factors that to increase life expectancy. Furthermore, we need to change our lifestyle 
to be healthy and well-being in our lives and to extend to years of life. To get a better 
and longer life, as personally, we should do exercise regularly, eat the healthy food, avoid 
the alcohol, cigarette and fast food which may get side effect for our health, reduce our 
stress as much as possible, be optimistic and be happy with other people.  
For the whole country’s performance, our government needs to provide human 
basic needs and infrastructure of their citizens. And they must reduce unemployment and 
inequality, build human capital, provide effective health care system, educate their 
citizens concerning with health’s knowledge.  
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APPENDIX A 
STATA Output for Table 4, Model (1): Infant Mortality Rate and Public Health 
Expenditures (ASEAN) 
 
 
 
 
 
 
 
 
 
F test that all u_i=0: F(4, 82) = 605.13                     Prob > F = 0.0000
                                                                              
         rho    .99649555   (fraction of variance due to u_i)
     sigma_e    .03963267
     sigma_u    .66831457
                                                                              
       _cons     13.84048   1.206387    11.47   0.000     11.44059    16.24037
     LPofHIV    -.0214069   .0211845    -1.01   0.315    -.0635496    .0207359
        LMMR     .2601157   .0714549     3.64   0.000     .1179691    .4022622
        LGDP     .5365565   .0484304    11.08   0.000      .440213    .6329001
        LFPI    -.4483049   .0701983    -6.39   0.000    -.5879518   -.3086581
         LUP    -1.082012   .0785748   -13.77   0.000    -1.238322   -.9257015
        LIWS    -3.703347   .4957747    -7.47   0.000    -4.689601   -2.717093
        LISF     1.527165   .2335454     6.54   0.000     1.062569    1.991761
        LPHE    -.0545521   .0219113    -2.49   0.015    -.0981407   -.0109635
                                                                              
        LIMR        Coef.   Std. Err.      t    P>|t|     [95% Conf. Interval]
                                                                              
corr(u_i, Xb)  = 0.3275                         Prob > F          =     0.0000
                                                F(8,82)           =     453.21
     overall = 0.4971                                         max =         19
     between = 0.4993                                         avg =       19.0
     within  = 0.9779                                         min =         19
R-sq:                                           Obs per group:
Group variable: Country1                        Number of groups  =          5
Fixed-effects (within) regression               Number of obs     =         95
. xtreg LIMR LPHE LISF LIWS LUP LFPI LGDP LMMR LPofHIV,fe
APPENDIX B 
STATA Output for Table 4, Model (2): Infant Mortality Rate and Public Health 
Expenditures (ASEAN) excluding LSF from Model (1) 
 
 
 
 
 
 
 
 
F test that all u_i=0: F(4, 83) = 395.97                     Prob > F = 0.0000
                                                                              
         rho    .99357808   (fraction of variance due to u_i)
     sigma_e     .0485904
     sigma_u    .60439254
                                                                              
       _cons     8.720257   1.125166     7.75   0.000     6.482347    10.95817
     LPofHIV     .0608221   .0209018     2.91   0.005     .0192493    .1023949
        LMMR     .1693345   .0859357     1.97   0.052    -.0015881    .3402571
        LGDP     .3503422   .0480273     7.29   0.000     .2548178    .4458666
        LFPI    -.5621671   .0833748    -6.74   0.000    -.7279962   -.3963381
         LUP    -1.065324   .0962834   -11.06   0.000    -1.256828   -.8738201
        LIWS    -.5651703    .152519    -3.71   0.000    -.8685244   -.2618163
        LPHE    -.0256318   .0263108    -0.97   0.333    -.0779629    .0266993
                                                                              
        LIMR        Coef.   Std. Err.      t    P>|t|     [95% Conf. Interval]
                                                                              
corr(u_i, Xb)  = 0.3183                         Prob > F          =     0.0000
                                                F(7,83)           =     340.52
     overall = 0.5845                                         max =         19
     between = 0.5668                                         avg =       19.0
     within  = 0.9664                                         min =         19
R-sq:                                           Obs per group:
Group variable: Country1                        Number of groups  =          5
Fixed-effects (within) regression               Number of obs     =         95
. xtreg LIMR LPHE LIWS LUP LFPI LGDP LMMR LPofHIV,fe
APPENDIX C 
STATA Output for Table 4, Model (3): Infant Mortality Rate and Public Health 
Expenditures (ASEAN) excluding LISF and LGDP from Model (1) 
 
 
 
 
 
 
 
 
 
F test that all u_i=0: F(4, 84) = 266.83                     Prob > F = 0.0000
                                                                              
         rho     .9767391   (fraction of variance due to u_i)
     sigma_e    .06187545
     sigma_u    .40095381
                                                                              
       _cons     8.111004   1.428843     5.68   0.000     5.269592    10.95242
     LPofHIV     .0896207   .0261374     3.43   0.001     .0376435    .1415979
        LMMR     .2959284   .1071766     2.76   0.007      .082796    .5090608
        LFPI    -.1455784    .077353    -1.88   0.063    -.2994032    .0082465
         LUP    -1.197541    .120416    -9.95   0.000    -1.437001   -.9580805
        LIWS    -.3122551   .1891341    -1.65   0.102    -.6883691    .0638588
        LPHE     .0509727   .0307199     1.66   0.101    -.0101172    .1120627
                                                                              
        LIMR        Coef.   Std. Err.      t    P>|t|     [95% Conf. Interval]
                                                                              
corr(u_i, Xb)  = -0.3183                        Prob > F          =     0.0000
                                                F(6,84)           =     239.53
     overall = 0.8133                                         max =         19
     between = 0.8013                                         avg =       19.0
     within  = 0.9448                                         min =         19
R-sq:                                           Obs per group:
Group variable: Country1                        Number of groups  =          5
Fixed-effects (within) regression               Number of obs     =         95
. xtreg LIMR LPHE LIWS LUP LFPI LMMR LPofHIV,fe
APPENDIX D 
STATA Output for Table 5, Model (1): Life Expectancy and Public Health 
Expenditures (ASEAN)  
 
 
 
 
 
 
 
 
F test that all u_i=0: F(4, 82) = 408.22                     Prob > F = 0.0000
                                                                              
         rho    .99164743   (fraction of variance due to u_i)
     sigma_e    .00294102
     sigma_u    .03204546
                                                                              
       _cons     2.685451   .0895223    30.00   0.000     2.507362    2.863539
     LPofHIV    -.0026857    .001572    -1.71   0.091    -.0058129    .0004416
        LMMR    -.0141935   .0053024    -2.68   0.009    -.0247418   -.0036453
        LGDP    -.0132716   .0035939    -3.69   0.000     -.020421   -.0061222
        LFPI    -.0031158   .0052092    -0.60   0.551    -.0134786     .007247
         LUP     .0681287   .0058308    11.68   0.000     .0565294     .079728
        LIWS     .4296032   .0367899    11.68   0.000     .3564163    .5027901
        LISF    -.0993712   .0173307    -5.73   0.000    -.1338475   -.0648949
        LPHE     .0020523    .001626     1.26   0.210    -.0011823    .0052868
                                                                              
         LLE        Coef.   Std. Err.      t    P>|t|     [95% Conf. Interval]
                                                                              
corr(u_i, Xb)  = -0.5005                        Prob > F          =     0.0000
                                                F(8,82)           =    1663.69
     overall = 0.8958                                         max =         19
     between = 0.8788                                         avg =       19.0
     within  = 0.9939                                         min =         19
R-sq:                                           Obs per group:
Group variable: Country1                        Number of groups  =          5
Fixed-effects (within) regression               Number of obs     =         95
. xtreg LLE LPHE LISF LIWS LUP LFPI LGDP LMMR LPofHIV,fe
APPENDIX E 
STATA Output for Table 5, Model (2): Life Expectancy and Public Health 
Expenditures (ASEAN) excluding LMMR from Model (1) 
 
 
 
 
 
 
 
 
 
 
 
F test that all u_i=0: F(4, 83) = 423.06                     Prob > F = 0.0000
                                                                              
         rho    .99305268   (fraction of variance due to u_i)
     sigma_e    .00304829
     sigma_u    .03644466
                                                                              
       _cons      2.54739   .0758404    33.59   0.000     2.396547    2.698234
     LPofHIV    -.0011084   .0015106    -0.73   0.465    -.0041129    .0018961
        LGDP     -.013714    .003721    -3.69   0.000     -.021115   -.0063131
        LFPI      .003993   .0046449     0.86   0.392    -.0052454    .0132314
         LUP     .0685089   .0060417    11.34   0.000     .0564922    .0805255
        LIWS     .4308221   .0381289    11.30   0.000     .3549852    .5066589
        LISF     -.090358   .0176205    -5.13   0.000    -.1254045   -.0553115
        LPHE     .0011892   .0016518     0.72   0.474    -.0020962    .0044745
                                                                              
         LLE        Coef.   Std. Err.      t    P>|t|     [95% Conf. Interval]
                                                                              
corr(u_i, Xb)  = -0.3155                        Prob > F          =     0.0000
                                                F(7,83)           =    1768.95
     overall = 0.8387                                         max =         19
     between = 0.8041                                         avg =       19.0
     within  = 0.9933                                         min =         19
R-sq:                                           Obs per group:
Group variable: Country1                        Number of groups  =          5
Fixed-effects (within) regression               Number of obs     =         95
. xtreg LLE LPHE LISF LIWS LUP LFPI LGDP LPofHIV,fe
APPENDIX F 
STATA Output for Table 5, Model (3): Life Expectancy and Public Health 
Expenditures (ASEAN) excluding LMMR and LUP from Model (1) 
 
 
 
 
 
 
 
 
 
 
 
 
F test that all u_i=0: F(4, 84) = 155.66                     Prob > F = 0.0000
                                                                              
         rho    .98795832   (fraction of variance due to u_i)
     sigma_e    .00483789
     sigma_u    .04382091
                                                                              
       _cons     2.785076   .1156764    24.08   0.000     2.555041    3.015111
     LPofHIV    -.0017166   .0023959    -0.72   0.476    -.0064811    .0030479
        LGDP    -.0193845    .005852    -3.31   0.001    -.0310218   -.0077472
        LFPI     .0359101   .0058641     6.12   0.000     .0242487    .0475714
        LIWS     .3978962   .0603379     6.59   0.000     .2779076    .5178848
        LISF    -.0827763   .0279451    -2.96   0.004    -.1383481   -.0272045
        LPHE     .0103064     .00229     4.50   0.000     .0057525    .0148604
                                                                              
         LLE        Coef.   Std. Err.      t    P>|t|     [95% Conf. Interval]
                                                                              
corr(u_i, Xb)  = 0.4138                         Prob > F          =     0.0000
                                                F(6,84)           =     810.83
     overall = 0.7837                                         max =         19
     between = 0.7759                                         avg =       19.0
     within  = 0.9830                                         min =         19
R-sq:                                           Obs per group:
Group variable: Country1                        Number of groups  =          5
Fixed-effects (within) regression               Number of obs     =         95
. xtreg LLE LPHE LISF LIWS LFPI LGDP LPofHIV,fe
  
 
 
 
 
 
 
 
 
 
 
BIBLIOGRAPHY 
 
 
 
 
 
 
 
 
 
 
 
REFERENCES 
Abel, N. (2014). ON HEALTH OUTCOMES IN EAST AFRICA : 
Bhalotra, S. (2007). SPENDING TO SAVE ? STATE HEALTH EXPENDITURE 
AND INFANT MORTALITY IN INDIA, 928(August), 911–928. 
https://doi.org/10.1002/hec 
Health, N., & Profiles, C. (2015). Maternal and Newborn Health Country 
Profiles, 1–6. 
Lu, C., Schneider, M. T., Gubbins, P., Leach-kemon, K., Jamison, D., Murray, 
C. J. L., … Foundation, M. G. (2001). Public financing of health in developing 
countries : a cross-national systematic analysis. The Lancet, 375(9723), 1375–1387. 
https://doi.org/10.1016/S0140-6736(10)60233-4 
Profile, C. H. (2014). Neonatal and Child Health Profile. 
Pyi, N., Council, T., & Index, H. D. (2012). BASIC INFORMATION Total 
population (million) Land area. 
Shetty, A., & Shetty, S. (2014). The correlation of health spending and infant 
mortality rate in Asian countries, 1(2), 100–105. https://doi.org/10.5455/2349-
3291.ijcp20140808 
Working, S. (2015). Effective Development Cooperation in the health sector in 
Myanmar Report of IHP + mission to Myanmar 26 - 31 August 2013 Andrew Cassels, 
Finn Schliemann, Phyllida Travis Key conclusions Much has already been achieved, in 
results and in coordination Five areas for follow-up 1. Health policies and strategy, 
(August 2013), 1–13. 
Zhang, X., & Kanbur, R. (2005). Spatial inequality in education and healthcare 
in China, 16, 189–204. https://doi.org/10.1016/j.chieco.2005.02.002 
